Samantha Valle-Oseguera, PharmD

Associate Professor
Department of Clinical Pharmacy
Valle-Oseguera
[email protected]
Phone: +1 559 499-6514
Fax: +1 559 499-6513
155 N Fresno Street, Rm 279
UCSF Box 0613
Fresno, CA 93701
United States

Links

UCSF Profiles Experiential Education

Affiliations

Education programs

Regional Program Director, Fresno Program, PharmD Degree Program
UCSF Fresno Pharmacy Program

What I do

My clinical practice site is at Kaweah Health Medical Center, where I serve as an ambulatory care clinical pharmacist at a primary care rural clinic. In addition, I am a preceptor for Kaweah Health's PGY2 Ambulatory Care residents and UCSF APPE pharmacy students assigned to the Fresno Program. My areas of interest involve development of pharmacy service lines to care for underserved populations, interprofessional collaborations, and diabetes comanagement.

Departmental research area

clinical research

My research expertise

interprofessional collaborations, Medicare Part D, care for underserved populations, pharmacy leadership

Clinical expertise

chronic disease state management, geriatrics

Professional background

Degrees

PharmD, University of the Pacific
BS, Biotechnology, University of California, Davis

Postgraduate training

PGY2, Ambulatory Care Residency, Boise VA Medical Center
PGY1, Pharmacy Practice Residency, Boise VA Medical Center

Research keywords

  • Dental Records
  • Inappropriate Prescribing
  • prescription drugs
  • Interprofessional Relations
  • contracts
  • Cooperative Behavior
  • pharmacists
  • Independent Living
  • Medicare Part D
  • Dental Care
  • pharmacies
  • Prediabetic State
  • Dentists
  • pharmacy
  • Organizational Objectives

Publications

Gadd S, Lopez CE, Nelson CA, Le TQ, Valle-Oseguera CS, Cox N, Buu J, Turner K. Identifying key roles of the pharmacy technician in primary care settings. Am J Health Syst Pharm. 2022 03 07; 79(6):460-466.
Valle-Oseguera CS, Ranson CA, Tam P, Le J, Le B, Kozono M, Park J, Tam A, Chen M, Rogan EL, Patel RA. Factors Associated With a Higher Risk of Undiagnosed Prediabetes in a Community-Dwelling Medicare Population. Sr Care Pharm. 2020 Feb 01; 35(2):85-92.
Rogan EL, Ranson CA, Valle-Oseguera CS, Lee C, Gumberg A, Nagin BN, Cao W, Wang E, Trinh C, Chan K, Samra NK, Hou EW, Patel RA. Factors associated with medication-related problems in an ambulatory medicare population and the case for medication therapy management. Res Social Adm Pharm. 2020 Jun; 16(6):783-786.
Rogan EL, Ranson CA, Mori TK, Park SK, Lam HM, Legaspi JF, Tran LK, Cameros CJM, Blackburn AN, Lee ST, Valle-Oseguera CS, Pham CN, Woelfel JA, Patel RA. Exploring the Valley of Savings: Minimizing Part D Costs and Optimizing Drug Therapy Outcomes in Medicare Beneficiaries With Developmental Disability. Intellect Dev Disabil. 2019 06; 57(3):234-241.
Patel R, Zhu L, Sohal D, Lenkova E, Koshki N, Woelfel J, Ranson C, Valle-Oseguera CS, Rogan EL. Use of 2015 Beers Criteria Medications by Older Medicare Beneficiaries. Consult Pharm. 2018 Jan 01; 33(1):48-54.
Boyce EG, Vyas D, Rogan EL, Valle-Oseguera CS, O'Dell KM. Impact of tofacitinib on patient outcomes in rheumatoid arthritis - review of clinical studies. Patient Relat Outcome Meas. 2016; 7:1-12.
Valle-Oseguera C, Boyce EG. Dentists and Pharmacists: Paradigm Shifts and Interprofessional Collaborative Practice Models. J Calif Dent Assoc. 2015 Oct; 43(10):591-5.